16 results
8-K
EX-2.1
MIRM
Mirum Pharmaceuticals Inc
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
, all “Material Adverse Effect” qualifications and other materiality qualifications contained in such representations and warranties shall … Representations of Seller contained in this Agreement that are qualified by “Material Adverse Effect” qualifications and other materiality qualifications
8-K
MIRM
Mirum Pharmaceuticals Inc
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
and warranties set forth in the Agreement (subject to customary materiality qualifiers) and material compliance with covenants set forth in the Agreement and (v … to standards of materiality applicable to the contracting parties that differ from those applicable to security holders of the Company. Investors
8-K
EX-10.1
uyixg6kydieg5j2x
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
8-K
EX-10.1
4uqap
19 Nov 21
Entry into a Material Definitive Agreement
6:08am
8-K
EX-10.1
cl7wayfze1l cg
29 Sep 21
U.S. FDA Approves LIVMARLI (maralixibat) as the First and Only Approved Medication for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome One Year of Age and Older
4:42pm
8-K
EX-99.1
7tgh0tt
10 Dec 20
Revenue Interest Purchase Agreement
9:11am
8-K
EX-99.2
88qh7
10 Dec 20
Revenue Interest Purchase Agreement
9:11am
S-3
EX-1.2
4j74x8sdhtivig8awpyv
3 Aug 20
Shelf registration
9:00am
S-1/A
EX-10.18
lt1e35et0 kony
8 Jul 19
IPO registration (amended)
6:43am
S-1
EX-10.20
a4hu y45frquu
21 Jun 19
IPO registration
3:24pm
S-1
EX-10.18
jtj33s
21 Jun 19
IPO registration
3:24pm
DRS
EX-10.20
q1b7sk
18 Apr 19
Draft registration statement
12:00am
DRS
EX-10.18
za71zn
18 Apr 19
Draft registration statement
12:00am
- Prev
- 1
- Next